Background: Vanuatu was formerly highly endemic for lymphatic filariasis (LF), caused by Wuchereria bancrofti and transmitted by Anopheles mosquitoes. After a baseline survey showing 4.8% antigen prevalence in 1998, the country conducted nationwide (in one implementation unit) annual mass drug administration (MDA) with albendazole and diethylcarbamazine citrate from 2000 to 2004 and achieved prevalence of 0.2% by 2006 in a representative nationwide cluster survey among all age groups.
Background
Vanuatu is a Pacific Island nation and one of the 16 Pacific Island countries and territories included in the Pacific Programme to Eliminate Lymphatic Filariasis (PacELF) started in 1999 [1, 2] . PacELF is part of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) which was launched in 2000 and aims to eliminate lymphatic filariasis (LF) as a public health problem by 2020 [3] . Elimination as a public health problem in this context includes interruption of transmission by mosquitoes and provision of services for those suffering from acute and chronic LF morbidity (acute attacks of lymphangitis, lymphoedema/elephantiasis and hydrocele).
Vanuatu is known to have been highly endemic for LF, based on a few surveys conducted prior to 1997, which have been reviewed in [4] . Some control efforts using mass drug administration (MDA) for up to 3 years in seven islands did not succeed in interrupting transmission [5] . At the start of the PacELF control programme in Vanuatu in 1999, the national LF antigen prevalence measured by immunochromatographic test (ICT) was estimated to be 4.8% in a baseline survey of 51 villages. Through intense efforts of annual MDA campaigns combining albendazole and diethylcarbamazine citrate (DEC) with vector control, antigen prevalence was reduced to 0.2% by 2006 as estimated in a survey of 90 household clusters. Programme implementation and MDA campaigns from 2000 until the final round of MDA in 2004 and the stop MDA survey in 2006 have been previously reported [4] . The current paper reviews the monitoring and post-MDA surveillance activities (including spot check site surveys after 2004) as evidence towards validation of elimination of LF as a public health problem according to current WHO validation process [6] . Available information on morbidity is also included in the present paper.
The monitoring and surveillance framework GPELF 2000 guidelines: Initially the Vanuatu LF programme followed the first (2000) GPELF guidelines [7] . These called for a mapping survey to assess LF endemicity in designated implementation units, testing of at least two sentinel sites and two spot check sites at baseline before the first round of MDA and during MDA, and, after achieving a microfilariae (Mf ) prevalence rate of less than 1% in these sites, performing a lot quality assurance sampling (LQAS) survey of 3000 children aged 6-10 years, born after the initiation of effective MDA rounds. The LQAS survey was designed to determine whether further MDA rounds can be stopped using a cut-off of <0.1% circulating filariasis antigen (CFA) prevalence.
PacELF 2003 guidelines: Due to small population sizes of some Pacific Island countries and the lack of tests able to determine such a low level cut-off, the PacELF developed its own monitoring and evaluation (M&E) framework in 2003 and 2004 for assessing interruption of transmission [1] . This framework stipulated a community cluster survey of all ages, and MDA to be stopped if antigen prevalence was <1%. In the PacELF terminology, the baseline survey was A, the sentinel site surveys B, and the stop MDA survey was the C survey. The D survey was the LQAS survey among children as proposed by the GPELF.
Modified 2005 GPELF guidelines: In 2005, the GPELF published the revised M&E guidelines [8] which recommended increased numbers of sentinel and spot check surveys be conducted before the fifth MDA to determine whether the Mf prevalence in all of the sampled sites was <1%. To determine whether MDA should be stopped, the LQAS survey of 3000 children was retained, but the recommended age group was changed to school entrants. However, Vanuatu was already in the process of conducting a C survey in all age groups in 2005 [4] , rather than following the 2005 GPELF guidelines.
Modified PacELF 2008 guidelines: In 2007, the PacELF proposed a new surveillance framework that was modified in 2008 [9] for the Pacific countries, including Vanuatu. These guidelines retained the community-based cluster C survey in all ages for the stopping MDA decision with a threshold of 1% antigen prevalence but modified the D survey to a child transmission survey (CTS). The CTS had a target sample size of all children aged 5 in a country (with the exception of PNG), to detect antigen positive children, either in school or community-based sur- Table 1 shows the summarised timeline of activities between 1997 and 2012, including specific timing of post MDA surveillance and follow-up activities described in this paper.
Methods

LF programme timeline
Following the baseline survey in 1997 and 1998, annual MDA rounds were conducted for five consecutive years nationwide during 2000-2004, with reported national coverage rates of 83, 84, 84, 87 and 85% respectively [1, 4, 11] . Sentinel site B surveys were started in eight villages in 2002 [12] . Spot-check site surveys were also initiated in several villages and hospitals 
Results
Sentinel and spot-check site surveys and targeted MDAs
As reported previously and summarised in Table 2 . All sentinel sites showed a decline in CFA prevalence over time, and five of the six sites had reached 0% CFA prevalence by 2006. The remaining site with persistent positives was Wanur in South Pentecost, Penama province. The locations of the sentinel sites are indicated in Fig. 1 .
Some additional villages were sampled as spot-check sites, some of them more than once, from 2002 onwards. These surveys are also compiled in Table 2 , with locations of the sites indicated in Fig. 1 . The surveys tested all age groups, with additional tests done on 3-6 year olds or 6-7 year olds in certain villages, as shown as footnotes to the table.
It can be noted from Table 2 ). The survey of 188 children aged 3-6 years in the same area found no CFA positives.
In South Pentecost in 2008, a spot-check survey found 3.9% CFA prevalence in a newly sampled site, Point Kross. Additional testing of 3 to 6 year olds only was done in 4 villages in South Pentecost in 2008: Point Kross, Londar/Baemateli, Namaram and the former sentinel site Wanur (Table 2) In 2011, ICT testing (N = 1100) was also conducted at 2 main hospitals (in Santo and Port Vila) on persons presenting for malaria examinations, and zero CFA positives were found. As for migrant screening, the programme tested 101 students who came to study at the University of South Pacific in Port Vila from other Pacific Island countries and found zero CFA positives. The formerly positive persons in all 8 
Transmission assessment surveys
The C survey of 2005/2006 is now referred to as TAS 1, although it was done in all ages rather than children aged 6-7 years as recommended by the transmission assessment surveys (TAS) protocol [10] . Results were presented in [4] . (Table 3 ). There were 25 teams in total and 2 to 6 teams were assigned per province. The teams covered 86.2% of the target number of children in EU1, 52.3% in EU2 and 71.8% in EU3. No CFA positives were found among the 4752 children tested, aged 6-7 years, giving upper 95% confidence intervals for CFA prevalence of 0.2% in EU1, 1.0% in EU2 and 0.3% in EU3 (Table 3 ). The survey sample builder software [10] was not used for these surveys, but no positives were detected so the results were below any threshold that would have been generated. Thus, in TAS 2, all three EUs passed.
TAS 3 was conducted in 2010 and 2012 under GPELF 2011 guidelines [10] . EU1 and EU2 were surveyed in 2010 using a school-based approach, testing all first graders in the respective EUs. TAS 3 in EU3 initially tested only children in one sentinel site (Port Resolution, Tafea province) and one spot-check village (Ebule, Shefa province) in 2010. Completion of the TAS 3 in EU3 in all other school-aged children was done in 2012. Over both years combined, 63.2% (77.1% in EU1, 90.1% in EU2 and 40.8% in EU3) of all 6-7-year-old children in the three EUs were tested with ICT (estimated total population N = 7086) ( Table 4 ) and no CFA positives were found among the 4480 children tested. Despite the low sampling proportion in EU3, all three EUs passed the TAS 3 (Table 4) , as the results were below the critical cut-offs (first integer <0.02N, where N is the estimated population in each EU). The TAS 3 in EU2 was conducted with support from the Task Force for Global Health, and the results have been published in summary form [13] .
A TAS 4 was performed only in EU2 (Penama province) in 2012 (Table 5 ). The estimated total population of 6-7-year-old children was 1034 in the EU. Two ICT positive children were found out of 933 tested. The critical cut-off was 20 and therefore EU2 passed TAS 4 [10] . The results of the TAS 4 have been published in summary form [13] .
Morbidity burden estimates
In 2003, the LF programme attempted to identify all persons with LF morbidity in the country by enlisting health staff to investigate during the MDA round. A morbidity survey form was inserted into the 2003 MDA registration books, and nurses were instructed to record any morbidity patients in their area on the forms which were submitted back to the national programme after the MDA. The resulting estimates are shown in Table 6 , and the numbers and location by island in Fig. 2 . A total of 95 cases were found in 2003, with two thirds being in males; about one third of cases were hydroceles or mixed hydroceles, or mixed limb and breast-related morbidities. In 2007, during the CTS/TAS 2, an attempt was made to determine an updated estimate and case register of LF morbidity cases with local nurses. The teams carried with them sufficient morbidity kits for all the previously identified cases (care charts, basins, towels and bars of soap) after the team members were trained in morbidity management. At this second round of the assessment, only 32 people with morbidity were followed up (18 males and 10 females, 4 in Sanma province with unknown gender) compared to 95 in 2003 (Table 6) ; however, it was reported that some of the survey teams did not have time to do thorough morbidity assessment. The cases recorded in 2007 were all above 60 years of age, and again, the majority had limb-related morbidity rather than hydroceles. Decrease in numbers of cases between 2003 and 2007 was seen in all provinces, with the biggest decrease being on Pentecost Island in Penama province (EU2).
Availability of hydrocele surgery and numbers performed
During the period 1998 to 2006, hydrocele surgery was available in Port Vila hospital, and an estimated 10-15 surgeries were performed during that period on hydroceles of stages 2 to 4 [14] . After 2006, this surgery was not available in Vanuatu until a visit by the external surgeon in November 2015. There were at least 23 cases of hydroceles with surgical backlog, of which eight cases were presented for examination. However, out of these 8 patients selected by referring physicians with a diagnosis of hydrocele, all 8 were actually confirmed as inguinal hernia. All were of big size, most of them were non reducible and none was strangled. While no hydrocelectomy was performed at that time, the fact that all referred cases were hernia indicates the need for further training in the differential diagnosis of hydroceles and poses the question of the real number of remaining patients affected by "hydroceles" out of the remaining 15 (23 minus 8) from Table 4 as part of post-validation activities of LF morbidity management.
Discussion and Conclusions
Vanuatu's national CFA prevalence by ICT before MDA in 1998 was 4.8% (N = 4362) and after MDA in 2005 was 0.2% (N = 7580) [4] . When considered by EU, which is a combination of provinces used to design sampling frames for the C survey/TAS 1 in 2005/2006, the CFA prevalence immediately after MDA was 0.1% in EU1 comprising Torba, Sanma and Malampa (N = 2790 tested), 0.2% in EU2 Penama (N = 2592 tested) and 0% in EU3 comprising Shefa and Tafea provinces (N = 2198 tested). This paper reports the details about monitoring activities during the MDA and the post MDA surveillance period. In the TAS 2 and 3, all three EUs passed according to the WHO criteria. Due to concerns about persistence of high prevalence of 3.9% in at least one village identified in 2008, an additional TAS 4 was conducted in Penama province only (EU2) in 2012. In this TAS 4, EU2 passed; although there were 2 CFA positive children discovered, the number of positives was well below the TAS threshold. Further post validation surveillance, including antibody tests in children, 
